Immunotherapies for cancer have progressed enormously over the past few decades, and
hold great promise for the future. The successes of these therapies, with some patients …

Cancer immunotherapies have revolutionized the treatment of numerous cancers, with
exciting results often superior to conventional treatments, such as surgery and …

Background Immunotherapy consists of activating the patient's immune system to fight
cancer and has the great potential of preventing future relapses thanks to immunological …

Advances in immuno‐oncology have significantly improved cancer therapy outcomes.
Unfortunately, potent responses to immunotherapy have only been achieved in subsets of …

Cancer immunotherapy has recently shown dramatic clinical success inducing durable
response in patients of a wide variety of malignancies. Further improvement of the clinical …

Macroscale biomaterials, such as preformed implantable scaffolds and injectable soft
materials, possess powerful synergies with anti-cancer immunotherapies. Immunotherapies …

Cancer immunotherapy, as a paradigm shift in cancer treatment, has recently received
tremendous attention. The active cancer vaccination, immune checkpoint blockage (ICB) …

Background The immune system interacts with cancer cells in various intricate ways that can
protect the individual from overproliferation of cancer cells; however, these interactions can …

Cancer immunotherapy is set to emerge as the future of cancer therapy. However, recent
immunotherapy trials in different cancers have yielded sub‐optimal results, with durable …

Cancer immunotherapy agents fight cancer via immune system stimulation and have made
significant advances in minimizing side effects and prolonging the survival of patients with …